Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
Institutes and Centers
The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy fosters discoveries to enable physicians to determine the specific genetic and molecular abnormalities in each patient's cancer, and then to prescribe the appropriate therapy that targets those abnormalities. Primary work is designed to identify the laboratory discoveries with the greatest potential to lead to innovative anticancer agents, diagnostic mechanisms to identify key targets in a patient's tumor and predictive and prognostic markers. The Institute involves research on new surgical and radiation therapy techniques, diagnostic imaging and pathologic evaluation of cancer as well as symptom management, palliative care and integrative medicine.
This Institute will expand a number of programs that support our clinical trials, including: